Manufacturing

Articles

REGENXBIO has opened a new in-house facility at its headquarters in Rockville, Md., that will be used to manufacture AAV gene therapies at commercial scale.

REGENXBIO Launches New Gene Therapy Manufacturing Facility in US

Astellas Pharma has opened its new gene therapy manufacturing facility in Sanford, NC, which will support clinical- and commercial-scale manufacturing of AAV vectors for gene therapies.

Astellas Opens New US-based Large-Scale Gene Therapy Manufacturing Facility

Eli Lilly and Company plans to build two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Lilly to Invest $2.1 Billion in New Indiana Manufacturing Facilities

AGC Biologics is investing in viral vector suspension technology at its new Longmont, Colo., facility.

AGC Biologics Adds Viral Vector Suspension Technology at New US Campus

Through a collaboration, Avantor and Cytovance Biologics will accelerate plasmid optimization and sourcing services for viral vectors and mRNA-based vaccines and therapeutics.

Avantor and Cytovance Biologics Partner on Plasmid DNA Development

Feliza Mirasol is the science editor for 

Complex hurdles complicate the development of emerging therapies.

Emerging Therapies Face Development Hurdles

Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.

Emerging Plant-based Platform for Biomanufacturing

VectorBuilder will expand with the construction of new $500 million Gene Delivery Research and Manufacturing Campus in Guangzhou, China.

VectorBuilder to Expand with $500 Million Gene Delivery Research and Manufacturing Campus

UCB has announced it will build a new innovative gene therapy facility in Belgium.

UCB Expands Innovation Footprint with New Gene Therapy Facility

CGTs offer hope for the future of treatments, but the costly manufacturing, slow turnaround time, and need for supplies hinder progress.

Manufacturing, Gene Therapies